Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Toshihiko TAKENAKA"'
Autor:
Yoshiaki Taniguchi, Hyuma Makizako, Yuki Nakai, Yuto Kiuchi, Shoma Akaida, Mana Tateishi, Toshihiko Takenaka, Takuro Kubozono, Mitsuru Ohishi
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 20; Pages: 6172
Bone and muscle mass loss are known to occur simultaneously. The alpha-actinin three (ACTN3) genotype has been shown to potentially affect bone and muscle mass. In this study, we investigated the association between the ACTN3 genotype and bone and mu
Autor:
Akio Kimura, Ken Kanamasa, Tadahiko Yamamoto, Katsuhiko Katayama, Hiroki Furuta, Masaru Miyataka, Takahiro Hayashi, Toshihiko Takenaka, Kinji Ishikawa, Mitsugu Taniguchi
Publikováno v:
Japanese Heart Journal. 44:873-887
We retrospectively compared the incidence of cardiac events in myocardial infarction (MI) patients treated in our departments between 1990 and 1999 with pravastatin or without cholesterol-lowering agents. Our aim was to evaluate the efficacy of prava
Autor:
Kinji Ishikawa, Akio Kimura, Takaaki Taniwa, Toshihiko Takenaka, Takahiro Hayashi, Ken Kanamasa, null on behalf of the Secondary Prevention Group
Publikováno v:
Circulation Journal. 66:881-885
Recent trends in the treatment of post-myocardial infarction (MI) patients and the factors accounting for the improvement in outcome are presented. A total of 6,602 post-MI patients (5,320 males, 1,282 females; 58.9±10.4 years of age) enrolled betwe
Autor:
Akio Kimura, Kinji Ishikawa, Mayila Wufuer, Ken Kanamasa, Takahiro Hayashi, Toshihiko Takenaka
Publikováno v:
Japanese Circulation Journal. 65:879-886
This study investigated the association between blood pressure (diastolic [DBP] and systolic [SBP]) and cardiac events in a total of 6,602 patients with a healed myocardial infarction (MI) (5,320 men, 1,282 women; mean age, 58.9±10.4 years), includi
Autor:
Atsuhiro Kurooka, Keiichi Sugimura, Seijiro Shimada, Tatsuya Kai, Hirofumi Kino, Kinji Ishikawa, Toshihiko Takenaka
Publikováno v:
Nephrology. 5:105-108
SUMMARY: Tsukuba hypertensive mice (THM) are transgenic mice that carry both human renin and angiotensinogen genes and overexpress the human renin-angiotensin system (RAS). In the present study, the effect of lisinopril on deposition of macromolecula
Autor:
Kinji ISHIKAWA, Tadahiko YAMAMOTO, Ken KANAMASA, Takahiro HAYASHI, Toshihiko TAKENAKA, Akio KIMURA, Masaru MIYATAKA, Hiroshi YABUSHITA, Koji KITAYAMA, null on Behalf of the Secondary Prevention Group
Publikováno v:
Internal Medicine. 39:1020-1026
Objective Long-term nitrate therapy for ischemic heart disease may cause drug tolerance which diminishes its beneficial effects; consequently, intermittent administration of nitrates is recommended. With this regimen, however, the potential occurrenc
Autor:
Toshihiko Takenaka, Katsuhiko Katayama, Akio Kimura, Masaru Miyataka, Kouji Kitayama, Ken Kanamasa, Kinji Ishikawa, Hiroshi Yabushita, Takahiro Hayashi, Tatsu Inoki
Publikováno v:
Japanese Circulation Journal. 64:358-364
This analysis was carried out to clarify the capacity of metoprolol to prevent cardiac events in Japanese post-myocardial infarction patients during a follow-up period of 16.3 months. Cardiac events occurred in 44 of 650 patients treated without β-b
Publikováno v:
Cancer. 85:1369-1374
BACKGROUND Recent reports suggest a possible link between nifedipine (but not diltiazem) and an increased risk of cancer in patients being treated with calcium antagonists. METHODS A total of 1054 postmyocardial infarction patients were divided rando
Autor:
Kazuo Murakami, Atsuhiro Kurooka, Kinji Ishikawa, Toshihiko Takenaka, Tatsuya Kai, Akiyoshi Fukamizu, Keiichi Sugimura, Seijiro Shimada
Publikováno v:
Journal of Hypertension. 16:2045-2049
Objective To evaluate the relation of tissue-localized angiotensin II (Ang II) concentration with cardiac hypertrophy and glomerulosclerosis in Tsukuba hypertensive mice (THM) carrying both human renin and angiotensinogen genes. Design Thirty THM age
Autor:
Kinji Ishikawa, Seijiro Shimada, Tatsuya Kai, Toshihiko Takenaka, Atsuhiro Kurooka, Keiichi Sugimura
Publikováno v:
Japanese Circulation Journal. 62:599-603
The effects of L-158,809, an angiotensin II type 1 receptor antagonist, on cardiac hypertrophy and nephropathy were examined using Tsukuba hypertensive mice (THM) carrying both human renin and angiotensinogen genes. Nine male THM aged 20 weeks were a